1-3 of 3
Galia Rahav
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL

Ohad Benjamini, Tamar Tadmor, Abraham Avigdor, Rotem Gershon, Limor Klike, Nofar Atari, Bayan Abdelkader, Michal Mandelboim, Galia Rahav
Journal: Blood
Blood (2022) 140 (Supplement 1): 9900–9901.
https://doi.org/10.1182/blood-2022-167353
Published: 2022
Journal Articles

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Clinical Trials & Observations
Yair Herishanu, Galia Rahav, Shai Levi, Andrei Braester, Gilad Itchaki, Osnat Bairey, Najib Dally, Lev Shvidel, Tomer Ziv-Baran, Aaron Polliack, Tamar Tadmor, Ohad Benjamini, on behalf of the Israeli CLL Study Group
Journal: Blood
Blood (2022) 139 (5): 678–685.
https://doi.org/10.1182/blood.2021014085
Published: 2022
Includes: Supplemental data
Journal Articles

Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope™): Case Matched Analysis

Maria J.G.T. Vehreschild, MD, J. Janne Vehreschild, MD, Francisco M Marty, MD, John R Perfect, MD, Luis Ostrosky-Zeichner, MD, Galia Rahav, MD, Bernhardt Zeiher, MD, Misun Lee, PhD, Rochelle Maher, MD, Clint Lovell, MS, Marc Engelhardt, MD, Oliver A Cornely, MD
Journal: Blood
Blood (2014) 124 (21): 1151.
https://doi.org/10.1182/blood.V124.21.1151.1151
Published: 2014